Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/3 study evaluating Platelet Rich Fibrin combined with 1% alendronate to treat mandibular Degree II furcation defects; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet Rich Fibrin (platelet-rich fibrin)
  • alendronate (alendronate)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Furcation Defects | Phase 2, Phase 3 | Status: COMPLETED